Mesenchymal stromal cell therapy reverses detrusor hypoactivity in a chronic kidney patient

HIGHLIGHTS

  • who: Henrique Rodrigues Scherer Coelho and collaborators from the Center for Studies in Stem Cells, Cell and Genetic Toxicology (CeTroGen), Faculty of Medicine DrHu00e9lio (FAMED), Federal University of Mato Grosso do Sul (UFMS), Campo Grande, Mato Grosso do Sul, Brazil have published the paper: Mesenchymal Stromal Cell Therapy Reverses Detrusor Hypoactivity in a Chronic Kidney Patient, in the Journal: Biomedicines 2023, 218 of /2023/
  • what: In view of the above, this research reports a case of a patient with DH and chronic renal failure (CRF) treated with autologous mesenchymal stromal cells (AMSCs).

SUMMARY . . .

 

Logo ScioWire Beta black

If you want to have access to all the content you need to log in!

Thanks :)

If you don't have an account, you can create one here.

 

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?